GLP-1 drugs: what Healthy Connections paid

Q: Does a paid prescription mean Healthy Connections covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Healthy Connections shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Healthy Connections's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Healthy Connections’s payment record shows

In 2026Q1, the product Healthy Connections paid for most often was Ozempic®, at 9,600 prescriptions¹⁹ of the 13,864 to 14,125^{1,7,13,19,25,37,43} across all 8 products, or 69 percent of the published count.

Healthy Connections itself reimbursed at least $13,633,038 for these products in the quarter, about $985 per prescription. Pharmacies were paid $13,635,751 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,143.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Healthy Connections finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Healthy Connections. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Healthy Connections paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Healthy Connections paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 784¹	6%	$773,285	$773,285	$986
tirzepatideMounjaro®	Both2,638 managed care, 31 direct	at least 2,669⁷	19%	$2,527,553	$2,528,589	$947
semaglutideWegovy®	Both	at least 485¹³	4%	$554,165	$554,165	$1,143
semaglutideOzempic®	Both9,176 managed care, 424 direct	9,600¹⁹	69%	$9,550,322	$9,551,999	$995
semaglutideRybelsus®	Both	at least 174²⁵	1%	$167,419	$167,419	$962
liraglutideSaxenda®	Managed care	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	at least 77³⁷	<1%	$45,500	$45,500	$591
liraglutideliraglutide (generic)	Managed care	at least 46⁴³	<1%	$14,793	$14,793	$322

Healthy Connections publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 15.9 to 16.2 prescriptions per thousand people enrolled in Healthy Connections, on an average of 869,608 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 22 of the 168 product-quarters it holds a row for here, which is 13 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Healthy Connections pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Healthy Connections paid for each product, quarter by quarter

Prescriptions Healthy Connections paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld6 of 6 product codes withheld	at least 42 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$28,603 paid	at least 267 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$254,469 paid	at least 478 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$475,770 paid	at least 654 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$657,321 paid	at least 784 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$773,285 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 17 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$14,779 paid	at least 108 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$77,101 paid	at least 352 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$294,199 paid	at least 863 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$773,058 paid	at least 1,216 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$1,103,922 paid	at least 1,698 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$1,577,026 paid	at least 2,115 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$2,042,328 paid	at least 2,072 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$2,017,508 paid	at least 2,308 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$2,243,075 paid	at least 2,400 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$2,306,801 paid	at least 1,714 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$1,572,369 paid	at least 2,172 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$2,030,045 paid	at least 2,312 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$2,201,344 paid	at least 2,331 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$2,233,503 paid	at least 2,669 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$2,527,553 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld3 of 3 product codes withheld	at least 13 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$16,749 paid	at least 42 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$46,500 paid	at least 270 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$334,090 paid	at least 1,368 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$1,725,076 paid	at least 2,714 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$3,474,876 paid	3,167 paid prescriptions in the quarter (2025Q3)¹⁴Count$4,036,665 paid	at least 2,662 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$3,422,385 paid	at least 485 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$554,165 paid
semaglutideOzempic®range 3,112 to 9,681, up 129 on the quarter before	at least 1,922 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,494,291 paid	at least 2,341 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,817,659 paid	at least 2,537 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$1,968,728 paid	3,112 paid prescriptions in the quarter (2021Q4)²⁴Count$2,469,213 paid	3,580 paid prescriptions in the quarter (2022Q1)²³Count$2,980,140 paid	4,200 paid prescriptions in the quarter (2022Q2)²³Count$3,504,787 paid	at least 4,795 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$3,994,037 paid	at least 5,000 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$4,177,732 paid	at least 6,235 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$5,390,545 paid	at least 7,439 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$6,443,524 paid	at least 7,733 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$6,690,801 paid	at least 6,971 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$6,081,627 paid	at least 8,203 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$7,370,834 paid	at least 9,146 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$8,256,940 paid	at least 9,104 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$8,394,264 paid	8,683 paid prescriptions in the quarter (2024Q4)²¹Count$8,017,207 paid	9,566 paid prescriptions in the quarter (2025Q1)²⁰Count$9,030,545 paid	at least 6,575 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$6,222,130 paid	9,681 paid prescriptions in the quarter (2025Q3)²⁰Count$9,218,762 paid	9,471 paid prescriptions in the quarter (2025Q4)²⁰Count$9,124,222 paid	9,600 paid prescriptions in the quarter (2026Q1)¹⁹Count$9,550,322 paid
semaglutideRybelsus®	at least 45 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$33,455 paid	at least 76 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$56,754 paid	at least 149 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$120,191 paid	at least 160 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$128,352 paid	at least 203 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$176,426 paid	at least 220 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$183,909 paid	at least 249 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$207,482 paid	at least 282 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$240,392 paid	at least 347 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$306,214 paid	at least 386 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$333,171 paid	at least 418 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$364,217 paid	at least 401 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$347,647 paid	at least 446 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$403,738 paid	at least 389 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$350,965 paid	at least 300 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$278,024 paid	at least 235 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$213,222 paid	at least 156 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$142,957 paid	at least 153 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$147,245 paid	at least 171 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$161,722 paid	at least 136 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$128,930 paid	at least 174 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$167,419 paid
liraglutideSaxenda®range 14 to 23	23 paid prescriptions in the quarter (2021Q1)³⁶Count$18,910 paid	14 paid prescriptions in the quarter (2021Q2)³⁶Count$12,061 paid	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 118 to 1,503	1,348 paid prescriptions in the quarter (2021Q1)⁴²Count$1,105,094 paid	1,503 paid prescriptions in the quarter (2021Q2)⁴²Count$1,243,505 paid	1,358 paid prescriptions in the quarter (2021Q3)⁴²Count$1,104,152 paid	1,132 paid prescriptions in the quarter (2021Q4)⁴²Count$943,773 paid	898 paid prescriptions in the quarter (2022Q1)⁴¹Count$773,836 paid	873 paid prescriptions in the quarter (2022Q2)⁴¹Count$756,949 paid	834 paid prescriptions in the quarter (2022Q3)⁴¹Count$735,188 paid	737 paid prescriptions in the quarter (2022Q4)⁴¹Count$659,408 paid	577 paid prescriptions in the quarter (2023Q1)⁴⁰Count$523,418 paid	347 paid prescriptions in the quarter (2023Q2)⁴⁰Count$302,849 paid	252 paid prescriptions in the quarter (2023Q3)⁴⁰Count$225,542 paid	at least 222 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$201,221 paid	167 paid prescriptions in the quarter (2024Q1)³⁹Count$110,609 paid	118 paid prescriptions in the quarter (2024Q2)³⁹Count$77,827 paid	at least 80 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$48,970 paid	at least 31 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$21,040 paid	at least 21 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$11,968 paid	at least 36 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld³⁸At least$21,343 paid	at least 35 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld³⁸At least$22,564 paid	at least 49 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld³⁸At least$31,951 paid	at least 77 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld³⁷At least$45,500 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 33 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$20,296 paid	at least 39 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$21,528 paid	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable⁴⁴Withheld7 of 7 product codes withheld	at least 25 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$12,243 paid	at least 24 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$9,685 paid	at least 17 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$7,041 paid	at least 46 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$14,793 paid

What this page cannot tell you

Whether Healthy Connections covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open South Carolina in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, SC
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "219"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, SC
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "192"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, SC
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, SC
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like ZEPBOUND%, state SC, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, SC
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like ZEPBOUND%, state SC, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, SC
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like ZEPBOUND%, state SC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, SC
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "552"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, SC
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "494"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, SC
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "821"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, SC
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "574"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, SC
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO ", "suppression_used": "false", "number_of_prescriptions": "57"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, SC
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like MOUNJARO%, state SC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, SC
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "127"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, SC
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "903"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, SC
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "false", "number_of_prescriptions": "182"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, SC
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, SC
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like WEGOVY%, state SC, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, SC
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like WEGOVY%, state SC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, SC
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3411"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, SC
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3306"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, SC
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3336"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, SC
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "3138"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, SC
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "2362"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, SC
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC ", "suppression_used": "false", "number_of_prescriptions": "1653"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, SC
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "70"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, SC
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "74"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, SC
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "168"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, SC
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "194"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, SC
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "139"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, SC
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS ", "suppression_used": "false", "number_of_prescriptions": "85"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, SC
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like SAXENDA%, state SC, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, SC
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, SC
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, SC
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, SC
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, SC
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "23"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, SC
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "54"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, SC
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "28"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, SC
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "79"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, SC
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "301"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, SC
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "455"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, SC
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "875"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, SC
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state SC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "SC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "23"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, SC
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state SC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2025", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, SC
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state SC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "22"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, SC
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state SC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like LIRAGLUTID%, state SC, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, SC
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state SC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like LIRAGLUTID%, state SC, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, SC
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state SC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "SC", "product_name": "product_name like LIRAGLUTID%, state SC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 38 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 10 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Healthy Connections covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.